GMP accreditation for Cannatrek
Hemp Gazette reports that Cannatrek has attained Good Manufacturing Practice (GMP) accreditation for its $5 million Shepparton facility in Victoria. Supported by the Victorian Government, this is part of Cannatrek’s broader $17 million investment in the region, set to generate 70 local jobs within three years. Tommy Huppert, CEO of Cannatrek, highlighted the accreditation as a pivotal step for the company, expanding the local job market and career development. Northern Victoria’s representative Jaclyn Symes applauds the initiative, seeing Shepparton leading the way in plant-based medicine production. The GMP status will also boost international export opportunities.
Read more: https://hempgazette.com/news/cannatrek…
Information about studies provided by Cannatrek on this website is for education purposes only. It is not a substitute for professional health advice. Nothing contained in this site, or any external site linked to by Cannatrek, is intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professional’s advice. Cannatrek does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information provided on this website, or any external site linked to by Cannatrek. Further, Cannatrek accepts no responsibility for material contained in a website that is linked to this site. It is the responsibility of the user to make their own decisions about the accuracy, currency, reliability and correctness of information contained in linked external websites.
